REQUEST A DEMO
Total
USD $0.00
Search more companies

Moh Pharmaceutical Technologies Sdn. Bhd. (Malaysia)

Main Activities: Grape Vineyards
Full name: Moh Pharmaceutical Technologies Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Manufacturers, importers, exporters and traders of raw materials, healthcare products, personal care products and functional food, and conduct research and development and provide consultation on the above said products.

Headquarters
26, Jalan Apollo U5/187, Bandar Pinggiran Subang
Shah Alam; Selangor; Postal Code: 40150

Contact Details: Purchase the Moh Pharmaceutical Technologies Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Moh Pharmaceutical Technologies Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Moh Pharmaceutical Technologies Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Moh Pharmaceutical Technologies Sdn. Bhd. report to view the information.
Incorporation Date:
June 21, 1995
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Moh Research Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Moh Pharmaceutical Technologies Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-32.28%
Total operating revenue
-32.28%
Operating profit (EBIT)
-76.06%
EBITDA
-69.8%
Net Profit (Loss) for the Period
-74.86%
Total assets
-0.82%
Total equity
15.19%
Operating Profit Margin (ROS)
-23.13%
Net Profit Margin
-17.03%
Return on Equity (ROE)
-47.24%
Debt to Equity Ratio
-11.23%
Quick Ratio
1.57%
Cash Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?